{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:37:10Z","timestamp":1715819830068},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.7759\/cureus.60366","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T21:47:45Z","timestamp":1715809665000},"source":"Crossref","is-referenced-by-count":0,"title":["A Refractory Case of Rapidly Progressive Glomerulonephritis Due to Microscopic Polyangiitis"],"prefix":"10.7759","author":[{"given":"Virginia L","family":"Hoch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeetpal S","family":"Hans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Rapidly progressive glomerulonephritis","author":"Naik RH","year":"2024","unstructured":"Naik RH, Shawar SH. Rapidly progressive glomerulonephritis. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6369814","article-title":"Prognostic factors for survival and relapse in ANCA-associated vasculitis with renal involvement: a clinical long-term follow-up study","volume":"2018","author":"T\u00f6rnroth T","year":"2018","unstructured":"T\u00f6rnroth T, Poussa T, Ekstrand A. Prognostic factors for survival and relapse in ANCA-associated vasculitis with renal involvement: a clinical long-term follow-up study. Int J Nephrol. 2018, 2018:6369814. 10.1155\/2018\/6369814","journal-title":"Int J Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.15861219","article-title":"Treatment of granulomatosis with polyangiitis and microscopic polyangiitis: should type of ANCA guide the treatment?","volume":"15","author":"Tesar V","year":"2020","unstructured":"Tesar V, Hruskova Z. Treatment of granulomatosis with polyangiitis and microscopic polyangiitis: should type of ANCA guide the treatment?. Clin J Am Soc Nephrol. 2020, 15:1519-21. 10.2215\/CJN.15861219","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.023","article-title":"The diagnosis and classification of microscopic polyangiitis","volume":"48-49","author":"Kallenberg CG","year":"2014","unstructured":"Kallenberg CG. The diagnosis and classification of microscopic polyangiitis. J Autoimmun. 2014, 48-49:90-3. 10.1016\/j.jaut.2014.01.023","journal-title":"J Autoimmun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5534851","article-title":"Update in the management of ANCA-associated vasculitis: recent developments and future perspectives","volume":"2021","author":"Samman KN","year":"2021","unstructured":"Samman KN, Ross C, Pagnoux C, Makhzoum JP. Update in the management of ANCA-associated vasculitis: recent developments and future perspectives. Int J Rheumatol. 2021, 2021:10.1155\/2021\/5534851","journal-title":"Int J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-1-60","article-title":"ANCA-associated vasculitis","volume":"17","author":"Yates M","year":"2017","unstructured":"Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Lond). 2017, 17:60-4. 10.7861\/clinmedicine.17-1-60","journal-title":"Clin Med (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m421","article-title":"Management of ANCA associated vasculitis","volume":"368","author":"Wallace ZS","year":"2020","unstructured":"Wallace ZS, Miloslavsky EM. Management of ANCA associated vasculitis. BMJ. 2020, 368:m421. 10.1136\/bmj.m421","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3818-y","article-title":"Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes","volume":"37","author":"Shi L","year":"2017","unstructured":"Shi L. Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes. Rheumatol Int. 2017, 37:1779-88. 10.1007\/s00296-017-3818-y","journal-title":"Rheumatol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190065","article-title":"Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome","volume":"47","author":"Garcia-Vives E","year":"2020","unstructured":"Garcia-Vives E, Segarra-Medrano A, Martinez-Valle F, Agraz I, Solans-Laque R. Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome. J Rheumatol. 2020, 47:407-14. 10.3899\/jrheum.190065","journal-title":"J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne DR","year":"2017","unstructured":"Jayne DR, Bruchfeld AN, Harper L, et al.. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol. 2017, 28:2756-67. 10.1681\/ASN.2016111179","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne DR","year":"2021","unstructured":"Jayne DR, Merkel PA, Schall TJ, Bekker P. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021, 384:599-609. 10.1056\/NEJMoa2023386","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251172-a-refractory-case-of-rapidly-progressive-glomerulonephritis-due-to-microscopic-polyangiitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T21:47:49Z","timestamp":1715809669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251172-a-refractory-case-of-rapidly-progressive-glomerulonephritis-due-to-microscopic-polyangiitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.60366","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}